MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 54 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,052,465 | -30.1% | 1,472,331 | 0.0% | 2.91% | -41.2% |
| Q2 2023 | $10,085,467 | -12.1% | 1,472,331 | 0.0% | 4.94% | -10.5% |
| Q1 2023 | $11,469,458 | +2.4% | 1,472,331 | 0.0% | 5.52% | -25.4% |
| Q4 2022 | $11,204,439 | -6.9% | 1,472,331 | 0.0% | 7.40% | -7.4% |
| Q3 2022 | $12,029,000 | -15.5% | 1,472,331 | 0.0% | 7.99% | -21.4% |
| Q2 2022 | $14,237,000 | -31.0% | 1,472,331 | 0.0% | 10.16% | -8.8% |
| Q1 2022 | $20,642,000 | -31.3% | 1,472,331 | 0.0% | 11.14% | +5.0% |
| Q4 2021 | $30,065,000 | -8.3% | 1,472,331 | 0.0% | 10.61% | +62.2% |
| Q3 2021 | $32,804,000 | -1.8% | 1,472,331 | 0.0% | 6.54% | +22.2% |
| Q2 2021 | $33,422,000 | – | 1,472,331 | – | 5.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $11,469,458 | 5.52% |
| NEA Management Company, LLC | 7,692,298 | $59,923,001 | 4.14% |
| Cormorant Asset Management, LP | 2,893,717 | $22,542 | 1.48% |
| Alphabet Inc. | 1,464,015 | $11,404,677 | 0.63% |
| Avoro Capital Advisors LLC | 4,325,000 | $33,691,750 | 0.50% |
| Casdin Capital, LLC | 510,882 | $3,979,771 | 0.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $242,705 | 0.10% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $219,616 | 0.04% |
| UBS OCONNOR LLC | 95,528 | $744,163 | 0.02% |
| ExodusPoint Capital Management, LP | 261,593 | $2,038 | 0.02% |